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Personalized medicine is the ability to tailor healthcare
decisions based on an individual’s unique characteristics
(genetics, demographic information, healthcare experience,
environment and social factors) to more accurately diag-
nose the individual’s disease, predict its outcomes, and
select treatments that increase the chances of a successful
outcome and reduce possible adverse reactions. Moreover,
it is the ability to predict an individual’s susceptibility to
diseases with the goal of taking measures to prevent or
mitigate the extent to which an individual will experience
a disease. The promise of personalized medicine in health-
care delivery includes:
• avoiding the cost of a drug or therapy with little
chance of success for each patient
• avoiding exposing patients to side-effects from the
wrong treatment
• avoiding increased disease burden from delays in
finding the right treatment
• being able to act preventatively in cases where we
can predict disease susceptibility, to delay onset and/or
progression.
These changes in healthcare delivery promise
improved patient outcomes as well as reduced health-
care and societal costs of managing disease.
A key component in personalized medicine is the emer-
gence of whole-genome-scale sequencing as a platform to
identify gene variants. Many challenges exist, however, to
the use of large-scale sequencing in disease gene discovery
and the efficacious application of such knowledge to health
benefit. Leveraging upon the Ontario Government’s CAD
$7 million committed investment to build a clinical geno-
mics operational framework for personalized healthcare at
Mount Sinai Hospital, our project is developing a portfolio
of computational tools and methods to enable acquisition,
analysis, interpretation and reporting of high-throughput
sequence data and the ethical, economic, psychosocial and
knowledge synthesis support needed to move deep sequen-
cing datasets and their findings into clinical practice.
The challenges to moving next-generation sequencing
(NGS) into the hospital setting are both technical and reg-
ulatory. Since introduced into the research community in
2007, broad use of NGS has been greatly enabled by devel-
opment of sophisticated informatics and analytic tools.
While such tools have reduced many of the barriers to
clinical application of NGS, the investment needed to
bring NGS into medical practice remains significant, the
scale of IT required being unprecedented at most hospi-
tals. In this context, hospitals are, to some extent, at a
similar place to that of research institutes when NGS first
emerged. Some of the IT barriers to clinical use of NGS
have been bypassed by the expertise in NGS data manage-
ment developed at genome centers and across the research
community. However, even this wealth of experience does
not fully address the road blocks inherent to integrating
NGS information into existing health workflows and IT
systems, and the added challenges posed by the regulatory
controls in place across the health system.
This talk will describe strategies our group is using to
overcome these hurdles and thereby expedite clinical
integration of NGS capability and its translation to
delivery of personalized healthcare.
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